Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to estimate the prevalence of penicillin allergy, evaluate the diagnostic value of the allergologic work-up used in the study, and the health effects of penicillin allergy.


Clinical Trial Description

Penicillin allergy is the most common of self-reported drug allergies and un-verified penicillin allergy is a significant and growing public health problem. 10% of all patients report penicillin allergy. However, there is large discrepancy between reported penicillin allergy and true allergy. Despite its high prevalence, greater than 90% of such patients are in fact able to tolerate the medication without allergic reactions. In this study patients having a penicillin allergy label will be investigated to confirm or to exclude the allergy diagnosis. The diagnostic value of the allergen test panel and the allergologic work-up will be evaluated. Clinical parameters as well as immunological will be assessed. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03581604
Study type Interventional
Source Oslo University Hospital
Contact Eva Stylianou, Phd
Phone 004722118784
Email eva.stylianou@ous-hf.no
Status Recruiting
Phase N/A
Start date September 13, 2017
Completion date December 31, 2026

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05670756 - Preoperative Survey to Evaluate Patient Allergy
Not yet recruiting NCT06167564 - Allergy Diagnostic Test Based on Microchip Technology N/A